Spruce Biosciences, Inc. (SPRB) Total Assets by Year
Spruce Biosciences, Inc. closed fiscal year 2025 with $53.0M in total assets, $10.5M in total liabilities and $42.5M in shareholder equity. This represents an increase of 17.3% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Spruce Biosciences, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
SPRB Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K |
|---|---|---|---|---|---|---|---|
| Total Assets | $53.0M+17.3% | $45.2M-56.5% | $103.9M+21.4% | $85.6M-32.3% | $126.5M-22.3% | $162.9M+3371.5% | $4.7M |
| Total Liabilities | $10.5M-35.9% | $16.4M-40.3% | $27.4M+59.9% | $17.2M+13.5% | $15.1M+12.3% | $13.5M-61.9% | $35.3M |
| Total Equity | $42.5M+47.5% | $28.8M-62.3% | $76.5M+11.7% | $68.5M-38.5% | $111.4M-25.5% | $149.4M+587.7% | -$30.6M |
SPRB Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $102.9M+371.4% | $56.2M+77.5% | $53.0M+17.3% | $15.3M-76.5% | $21.8M-71.1% | $31.6M-63.8% | $45.2M-56.5% | $65.1M-42.4% | $75.5M-40.0% | $87.5M-37.1% | $103.9M+21.4% | $113.0M+18.6% |
| Total Liabilities | $19.1M+121.3% | $21.5M+31.8% | $10.5M-35.9% | $9.9M-26.3% | $8.6M-47.2% | $16.3M-21.9% | $16.4M-40.3% | $13.5M-51.2% | $16.4M-44.4% | $20.9M-32.8% | $27.4M+59.9% | $27.6M+64.1% |
| Total Equity | $83.7M+535.3% | $34.6M+126.1% | $42.5M+47.5% | $5.4M-89.6% | $13.2M-77.7% | $15.3M-77.0% | $28.8M-62.3% | $51.6M-39.5% | $59.2M-38.7% | $66.6M-38.3% | $76.5M+11.7% | $85.4M+8.8% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Spruce Biosciences, Inc. financials
Frequently Asked Questions
What was Spruce Biosciences, Inc.'s total assets in fiscal year 2025?
Spruce Biosciences, Inc. closed fiscal year 2025 with $53.0M in total assets, $10.5M in total liabilities and $42.5M in shareholder equity.
How fast is Spruce Biosciences, Inc.'s total assets growing?
Spruce Biosciences, Inc. (SPRB) total assets rose by 17.3% year over year, from $45.2M to $53.0M in fiscal year 2025.
How has Spruce Biosciences, Inc.'s total assets changed over the years?
Across the 7 fiscal years this page covers, Spruce Biosciences, Inc. (SPRB) total assets went from $4.7M in fiscal year 2019 to $53.0M in fiscal year 2025.
What was Spruce Biosciences, Inc.'s total assets in the most recent quarter?
Spruce Biosciences, Inc. (SPRB) reported $102.9M in total assets in Q2 2026. This represents an increase of 371.4% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Spruce Biosciences, Inc. (SPRB) reported on that line in every period on record.